The impact of varicella vaccination on paediatric herpes zoster epidemiology: a Canadian population-based retrospective cohort study
Tóm tắt
The impact of universal varicella vaccination on herpes zoster (HZ) risk in unvaccinated and vaccinated children, and its long-term influence on HZ epidemiology, remains unknown. We conducted a retrospective cohort study using population-based administrative health data for children born between 1993 and 2018 (n = 924,124). We calculated age-specific cumulative HZ incidence rates by vaccination status for cohorts born before (1993–1999) and after (2000–2018) programme implementation; results were used to calculate relative risk of HZ by age group, vaccination status and vaccine availability period. Annual HZ incidence rates were calculated for 1993–2018. HZ risk was higher among unvaccinated children compared to vaccinated children across age groups; 64% higher before universal vaccination (RR: 0.36, 95% CI: 0.33, 0.39), and 32% higher after universal vaccination (RR: 0.68, 95% CI: 0.64, 0.73). Among unvaccinated children, HZ risk was 60% lower after vaccine programme implementation (RR: 0.40, 95% CI: 0.38, 0.43). Two-dose receipt corresponded with a 41% lower risk of HZ compared to one-dose receipt (RR: 0.59, 95% CI: 0.53, 0.65). Crude annual HZ incidence rates declined 64% after programme implementation, with decreases observed across age groups. Universal varicella vaccination programme implementation corresponds to decreased paediatric HZ incidence across age groups, in both vaccinated and unvaccinated individuals. Results from this study can be used to help inform varicella vaccination programme decision-making in other countries.
Tài liệu tham khảo
Russell ML, Dover DC, Simmonds KA, Svenson LW (2014) Shingles in Alberta: before and after publicly funded varicella vaccination. Vaccine 32(47):6319–6324. https://doi.org/10.1016/j.vaccine.2013.09.018
Marra F, Chong M, Najafzadeh M (2016) Increasing incidence associated with herpes zoster infection in British Columbia. Canada BMC Infect Dis 16(1):1–13. https://doi.org/10.1186/s12879-016-1898-z
Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P et al (2009) The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J 28(11):954–959. https://doi.org/10.1097/INF.0b013e3181a90b16
Weinmann S, Naleway AL, Koppolu P, Baxter R, Belongia EA, Hambidge SJ et al (2019) Incidence of herpes zoster among children: 2003–2014. Pediatrics 144(1):1–9. https://doi.org/10.1542/peds.2018-2917
Weinmann S, Chun C, Schmid DS, Roberts M, Vandermeer M, Riedlinger K et al (2013) Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005–2009. J Infect Dis 208(11):1859–1868. https://doi.org/10.1093/infdis/jit405
Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF (2005) Incidence of herpes zoster, before and after varicella-vaccination–associated decreases in the incidence of varicella, 1992–2002. J Infect Dis. 191(12):2002–7. https://doi.org/10.1086/430325
European Centre for Disease Prevention and Control (2015). Varicella vaccination in the European Union. Stockholm. Available from: https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/Varicella-Guidance-2015.pdf
Harpaz R (2019) Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States. Expert Rev Vaccines 18(8):795–811. https://doi.org/10.1080/14760584.2019.1646129
Civen R, Marin M, Zhang J, Abraham A, Harpaz R, Mascola L et al (2016) Update on incidence of herpes zoster among children and adolescents after implementation of varicella vaccination, Antelope Valley, CA, 2000 to 2010. Pediatr Infect Dis J 35(10):1132–1136. https://doi.org/10.1097/INF.0000000000001249
Letellier MC, Amini R, Gilca V, Trudeau G, Sauvageau C (2018) Herpes zoster burden in Canadian provinces: a narrative review and comparison with Quebec provincial data. Can J Infect Dis Med Microbiol. https://doi.org/10.1155/2018/3285327
van Lier A, Lugnér A, Opstelten W, Jochemsen P, Wallinga J, Schellevis F et al (2015) Distribution of health effects and cost-effectiveness of varicella vaccination are shaped by the impact on herpes zoster. EBioMedicine 2(10):1494–1499. https://doi.org/10.1016/j.ebiom.2015.08.017
Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H (2005) Incidence of herpes zoster, 1997–2002. Epidemiol Infect 133(2):245–253. https://doi.org/10.1017/S095026880400281X
Alberta Health. Interactive health data application. [cited 2020 Sep 10]. Available from: http://www.ahw.gov.ab.ca/IHDA_Retrieval/
Weinmann S, Irving SA, Koppolu P, Naleway AL, Belongia EA, Hambidge SJ et al (2020) Incidence of herpes zoster among varicella-vaccinated children, by number of vaccine doses and simultaneous administration of measles, mumps, and rubella vaccine. Vaccine 38(37):5880–5884. https://doi.org/10.1016/j.vaccine.2020.05.006
Harpaz R, Leung JW (2019) The epidemiology of herpes zoster in the united states during the era of varicella and herpes zoster vaccines: changing patterns among children. Clin Infect Dis 69(2):345–347. https://doi.org/10.1093/cid/ciy954
Wormsbecker AE, Wang J, Rosella LC, Kwong JC, Seo CY, Crowcroft NS et al (2015) Twenty years of medically-attended pediatric varicella and herpes zoster in Ontario, Canada: a population-based study. PLoS ONE 10(7):e0129483. https://doi.org/10.1371/journal.pone.0129483
Wolfson LJ, Daniels VJ, Altland A, Black W, Huang W, Ou W (2020) The impact of varicella vaccination on the incidence of varicella and herpes zoster in the United States: updated evidence from observational databases, 1991–2016. Clin Infect Dis 70(6):995–1002. https://doi.org/10.1093/cid/ciz305
De Wals P, Blackburn M, Guay M, Bravo Phd G, Blanchette Msc D, Douville-Fradet M et al (2001) Burden of chickenpox on families: a study in Quebec. Can J Infect Dis 12(1):27–32. https://doi.org/10.1155/2001/361070
Baclic O, Pless R, Quach C (2016) An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) : varicella proof of immunity—2015 update. Ottawa, ON [cited 2020 Jun 5]. Available from: https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/healthy-living/varicella-proof-immunity-2015-update/varicella-varicelle-eng.pdf
First Nations and Inuit Health Branch (FNIHB)—Alberta region. Regional Communicable Disease Control Report, 2016. 2017.
Russell ML, Schopflocher DP, Svenson LW (2008) Health disparities in chickenpox or shingles in Alberta? Can J Public Heal 99(1):41–45
Marra F, Parhar K, Huang B, Vadlamudi N (2020) Risk factors for herpes zoster infection: a meta-analysis. Open Forum Infect Dis 7(1). https://doi.org/10.1093/ofid/ofaa005